论文部分内容阅读
目的探讨中西医结合疗法延长晚期非小细胞肺癌(NSCLC)生存期的优越性和优势环节。方法对经中西医结合治疗的生存期在2年以上的晚期NSCLC患者13例进行回顾性分析。结果在应用以含铂类方案为主的化疗同时,中医的益气养阴法及理气化痰法是该组患者最为常用的治法;在所应用的中药静脉制剂中,以康莱特注射液、生脉注射液等使用频率最高;中药汤剂中以茯苓、陈皮、白术、黄芪、沙参等药物最为常用。结论中西医结合疗法延长晚期NSCLC生存期的优势环节可能在于中医药对化疗的减毒、增效作用以及中西药物间的协同与叠加作用;益气养阴治法及理气化痰治法在晚期NSCLC的中医治疗中占有重要地位。
Objective To investigate the advantages and advantages of traditional Chinese and western medicine in prolonging the survival of advanced non-small cell lung cancer (NSCLC). Methods Retrospective analysis of 13 patients with advanced NSCLC who survived more than 2 years after the combination of TCM and Western medicine was performed. Results In the application of chemotherapy containing platinum-based chemotherapy at the same time, the traditional Chinese medicine Qi and Yin and phlegm method is the most common rule in this group of patients; in the application of traditional Chinese medicine intravenous preparations, Kanglaite Injection , Shengmai injection the highest frequency of use; traditional Chinese medicine decoction to Poria, Citrus, Atractylodes, Astragalus, Adenophora and other drugs most commonly used. Conclusion Integrative medicine therapy can prolong the survival of advanced NSCLC may be part of the advantage of traditional Chinese medicine on chemotherapy attenuated and synergistic effect and the synergy and superposition of Chinese and Western medicines between; Qi and Nourishing Yin and Qi and phlegm treatment in the late Chinese medicine treatment of NSCLC plays an important role.